Pharmacodynamic Biomarkers for Emerging LRRK2 Therapeutics

Genetic studies have identified variants in the LRRK2 gene as important components of Parkinson’s disease (PD) pathobiology. Biochemical and emergent biomarker studies have coalesced around LRRK2 hyperactivation in disease. Therapeutics that diminish LRRK2 activity, either with small molecule kinase...

Descripción completa

Detalles Bibliográficos
Autores principales: Kelly, Kaela, West, Andrew B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7438883/
https://www.ncbi.nlm.nih.gov/pubmed/32903744
http://dx.doi.org/10.3389/fnins.2020.00807

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7438883/
https://www.ncbi.nlm.nih.gov/pubmed/32903744
http://dx.doi.org/10.3389/fnins.2020.00807

Ejemplares similares